A long-acting anti–IL-8 antibody improves inflammation and fibrosis in endometriosis

子宫内膜异位症 医学 纤维化 炎症 病理生理学 盆腔疼痛 疾病 内科学 病理 免疫学 外科
作者
Ayako Nishimoto-Kakiuchi,Izumi Sato,Kiyotaka Nakano,Hiroshi Ohmori,Yoko Kayukawa,Hiromi Tanimura,Sachiya Yamamoto,Yuichiro Sakamoto,Genki Nakamura,Atsuhiko Maeda,Kentaro Asanuma,Atsuhiko Kato,Tadashi Sankai,Ryo Konno,Hisafumi Yamada‐Okabe
出处
期刊:Science Translational Medicine [American Association for the Advancement of Science]
卷期号:15 (684): eabq5858-eabq5858 被引量:104
标识
DOI:10.1126/scitranslmed.abq5858
摘要

Current pharmacological treatments for endometriosis are limited to hormonal agents that can relieve pain but cannot cure the disease. Therefore, the development of a disease-modifying drug for endometriosis is an unmet medical need. By studying human endometriotic samples, we found that the progression of endometriosis was associated with the development of inflammation and fibrosis. In addition, IL-8 expression was highly up-regulated in endometriotic tissues and closely correlated with disease progression. We created a long-acting recycling antibody against IL-8 (AMY109) and evaluated its clinical potency. Because rodents do not produce IL-8 and do not experience menstruation, we analyzed the lesions in cynomolgus monkeys that spontaneously developed endometriosis and in a surgically induced endometriosis monkey model. Both spontaneously developed and surgically induced endometriotic lesions demonstrated pathophysiology that was highly similar to that of human endometriosis. Once-a-month subcutaneous injection of AMY109 to monkeys with surgically induced endometriosis reduced the volume of nodular lesions, lowered the Revised American Society for Reproductive Medicine score as modified for monkeys, and ameliorated fibrosis and adhesions. In addition, experiments using cells derived from human endometriosis revealed that AMY109 inhibited the recruitment of neutrophils to endometriotic lesions and the production of monocyte chemoattractant protein-1 from neutrophils. Thus, AMY109 may represent a disease-modifying therapy for patients with endometriosis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
方源的应助被万念归一采纳,获得20
1秒前
2秒前
调皮的友儿完成签到,获得积分10
2秒前
CipherSage的应助被欣欣欣欣采纳,获得10
2秒前
旦旦完成签到 ,获得积分10
3秒前
3秒前
Moweikang完成签到,获得积分10
3秒前
cwlm12发布了新的文献求助10
4秒前
lalala发布了新的文献求助10
4秒前
眯眯眼的海完成签到,获得积分10
4秒前
4秒前
阿蒙蒙完成签到 ,获得积分10
4秒前
5秒前
李爱国的应助被非躺平人生采纳,获得10
5秒前
二三发布了新的文献求助10
5秒前
RobiN发布了新的文献求助10
6秒前
7秒前
SLL发布了新的文献求助10
7秒前
panduoba完成签到 ,获得积分10
8秒前
polymer1Ma完成签到,获得积分20
8秒前
欣欣欣欣完成签到,获得积分10
9秒前
10秒前
syvshc的应助被第一作者采纳,获得10
10秒前
斯文败类的应助被虚幻大有采纳,获得30
10秒前
老大车发布了新的文献求助10
11秒前
Sennir发布了新的文献求助30
11秒前
周雪完成签到 ,获得积分10
11秒前
11秒前
CodeCraft的应助被殷勤的马里奥采纳,获得10
12秒前
哈哈完成签到 ,获得积分10
12秒前
13秒前
忧郁秋凌发布了新的文献求助10
15秒前
起床做核酸完成签到,获得积分10
15秒前
polymer1Ma发布了新的文献求助10
16秒前
16秒前
16秒前
xiaogua完成签到,获得积分20
17秒前
陶醉白梅发布了新的文献求助10
17秒前
NexusExplorer的应助被楠楠采纳,获得10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188118
求助须知:如何正确求助?哪些是违规求助? 9575977
关于积分的说明 21844428
捐赠科研通 7785918
什么是DOI,文献DOI怎么找? 3435205
关于科研通互助平台的介绍 2559558
邀请新用户注册赠送积分活动 2482065